Literature DB >> 19451351

Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging.

Dao-Fu Dai1, Luis F Santana, Marc Vermulst, Daniela M Tomazela, Mary J Emond, Michael J MacCoss, Katherine Gollahon, George M Martin, Lawrence A Loeb, Warren C Ladiges, Peter S Rabinovitch.   

Abstract

BACKGROUND: Age is a major risk for cardiovascular diseases. Although mitochondrial reactive oxygen species have been proposed as one of the causes of aging, their role in cardiac aging remains unclear. We have previously shown that overexpression of catalase targeted to mitochondria (mCAT) prolongs murine median lifespan by 17% to 21%. METHODS AND
RESULTS: We used echocardiography to study cardiac function in aging cohorts of wild-type and mCAT mice. Changes found in wild-type mice recapitulate human aging: age-dependent increases in left ventricular mass index and left atrial dimension, worsening of the myocardial performance index, and a decline in diastolic function. Cardiac aging in mice is accompanied by accumulation of mitochondrial protein oxidation, increased mitochondrial DNA mutations and deletions and mitochondrial biogenesis, increased ventricular fibrosis, enlarged myocardial fiber size, decreased cardiac SERCA2 protein, and activation of the calcineurin-nuclear factor of activated T-cell pathway. All of these age-related changes were significantly attenuated in mCAT mice. Analysis of survival of 130 mice demonstrated that echocardiographic cardiac aging risk scores were significant predictors of mortality. The estimated attributable risk to mortality for these 2 parameters was 55%.
CONCLUSIONS: This study shows that cardiac aging in the mouse closely recapitulates human aging and demonstrates the critical role of mitochondrial reactive oxygen species in cardiac aging and the impact of cardiac aging on survival. These findings also support the potential application of mitochondrial antioxidants in reactive oxygen species-related cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19451351      PMCID: PMC2858759          DOI: 10.1161/CIRCULATIONAHA.108.822403

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  30 in total

Review 1.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease.

Authors:  Edward G Lakatta; Daniel Levy
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

Review 2.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging.

Authors:  Edward G Lakatta
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

3.  Quantification of random genomic mutations.

Authors:  Jason H Bielas; Lawrence A Loeb
Journal:  Nat Methods       Date:  2005-03-23       Impact factor: 28.547

4.  New model of health promotion and disease prevention for the 21st century.

Authors:  Robert N Butler; Richard A Miller; Daniel Perry; Bruce A Carnes; T Franklin Williams; Christine Cassel; Jacob Brody; Marie A Bernard; Linda Partridge; Thomas Kirkwood; George M Martin; S Jay Olshansky
Journal:  BMJ       Date:  2008-07-08

Review 5.  New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment.

Authors:  Michael R Zile; Dirk L Brutsaert
Journal:  Circulation       Date:  2002-03-26       Impact factor: 29.690

6.  Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.

Authors:  Julie St-Pierre; Stavit Drori; Marc Uldry; Jessica M Silvaggi; James Rhee; Sibylle Jäger; Christoph Handschin; Kangni Zheng; Jiandie Lin; Wenli Yang; David K Simon; Robert Bachoo; Bruce M Spiegelman
Journal:  Cell       Date:  2006-10-20       Impact factor: 41.582

7.  Cardiovascular changes by long-term inhibition of the renin-angiotensin system in aging.

Authors:  F Inserra; L Romano; L Ercole; E M de Cavanagh; L Ferder
Journal:  Hypertension       Date:  1995-03       Impact factor: 10.190

Review 8.  Abnormalities of calcium cycling in the hypertrophied and failing heart.

Authors:  S R Houser; V Piacentino; J Weisser
Journal:  J Mol Cell Cardiol       Date:  2000-09       Impact factor: 5.000

9.  Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice.

Authors:  Shouji Matsushima; Tomomi Ide; Mayumi Yamato; Hidenori Matsusaka; Fumiyuki Hattori; Masaki Ikeuchi; Toru Kubota; Kenji Sunagawa; Yasuhiro Hasegawa; Tatsuya Kurihara; Shinzo Oikawa; Shintaro Kinugawa; Hiroyuki Tsutsui
Journal:  Circulation       Date:  2006-04-03       Impact factor: 29.690

Review 10.  TGF-beta1 and angiotensin networking in cardiac remodeling.

Authors:  Stephan Rosenkranz
Journal:  Cardiovasc Res       Date:  2004-08-15       Impact factor: 10.787

View more
  225 in total

1.  Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria.

Authors:  Dao-Fu Dai; Tony Chen; Jonathan Wanagat; Michael Laflamme; David J Marcinek; Mary J Emond; Calvin P Ngo; Tomas A Prolla; Peter S Rabinovitch
Journal:  Aging Cell       Date:  2010-04-29       Impact factor: 9.304

Review 2.  Somatic mutations in aging, cancer and neurodegeneration.

Authors:  Scott R Kennedy; Lawrence A Loeb; Alan J Herr
Journal:  Mech Ageing Dev       Date:  2011-11-03       Impact factor: 5.432

Review 3.  Stochastic modulations of the pace and patterns of ageing: impacts on quasi-stochastic distributions of multiple geriatric pathologies.

Authors:  George M Martin
Journal:  Mech Ageing Dev       Date:  2011-09-22       Impact factor: 5.432

Review 4.  The effect of ageing on macrophage Toll-like receptor-mediated responses in the fight against pathogens.

Authors:  C R Dunston; H R Griffiths
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

Review 5.  Mitochondria and heart failure: new insights into an energetic problem.

Authors:  L Chen; A A Knowlton
Journal:  Minerva Cardioangiol       Date:  2010-04       Impact factor: 1.347

Review 6.  Applied Healthspan engineering.

Authors:  James W Larrick; Andrew Mendelsohn
Journal:  Rejuvenation Res       Date:  2010 Apr-Jun       Impact factor: 4.663

7.  Aging and Cardiac Fibrosis.

Authors:  Anna Biernacka; Nikolaos G Frangogiannis
Journal:  Aging Dis       Date:  2011-04       Impact factor: 6.745

8.  Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in Autoimmunity.

Authors:  Themis Alissafi; Lydia Kalafati; Maria Lazari; Anastasia Filia; Ismini Kloukina; Maria Manifava; Jong-Hyung Lim; Vasileia Ismini Alexaki; Nicholas T Ktistakis; Triantafyllos Doskas; George A Garinis; Triantafyllos Chavakis; Dimitrios T Boumpas; Panayotis Verginis
Journal:  Cell Metab       Date:  2020-07-31       Impact factor: 27.287

9.  Mitochondrial remodeling in mice with cardiomyocyte-specific lipid overload.

Authors:  Aly Elezaby; Aaron L Sverdlov; Vivian H Tu; Kanupriya Soni; Ivan Luptak; Fuzhong Qin; Marc Liesa; Orian S Shirihai; Jamie Rimer; Jean E Schaffer; Wilson S Colucci; Edward J Miller
Journal:  J Mol Cell Cardiol       Date:  2014-12-09       Impact factor: 5.000

10.  Pygopus maintains heart function in aging Drosophila independently of canonical Wnt signaling.

Authors:  Min Tang; Wuzhou Yuan; Xiongwei Fan; Ming Liu; Rolf Bodmer; Karen Ocorr; Xiushan Wu
Journal:  Circ Cardiovasc Genet       Date:  2013-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.